Feasibility and efficacy of laparoscopic restaging surgery for women with unexpected ovarian malignancy

• DOI: 10.1016/j.ejogrb.2015.06.027
• Publication Date: 2015-07-08T11:15:41Z
• Authors: Jaeman Bae; Joong Sub Choi; Won Moo Lee; A. Ra Koh; Un Suk Jung; Jung Hwa Ko; Jung Hun Lee
• Keywords: Adult; Ovarian Neoplasms; Incidental Findings; Adenosarcoma; Biopsy; Operative Time; Dysgerminoma; Middle Aged; Hysterectomy; Pelvis; 3. Good health; Intestines; 03 medical and health sciences; 0302 clinical medicine; Feasibility Studies; Humans; Lymph Node Excision; Female; Laparoscopy; Neoplasms, Cystic, Mucinous, and Serous; Omentum; Aorta; Neoplasm Staging

To evaluate the feasibility, surgical outcomes and complications of laparoscopic restaging surgery for women with unexpected ovarian malignancy.We conducted a retrospective chart review of 14 women with unexpected ovarian malignancy who underwent laparoscopic restaging surgery including peritoneal washing cytology, laparoscopic pelvic and paraaortic lymphadenectomy up to the left renal vein level, omentectomy, and multiple peritoneal biopsies, and hysterectomy except three fertility saving surgery.The median age and median body mass index women were 49 years (range, 22-63) and 24.2m/kg(2) (range, 18.9-25.3), respectively. The median operating time was 230min (range, 155-370). The median numbers of harvested pelvic and paraaortic lymph nodes were 26 (range, 6-41) and 18 (range, 2-40), respectively. The median return of bowel activity was 28h (range, 21-79). Four of the women were upstaged from the initial presumed stage. There were two intraoperative complications, laceration of the inferior vena cava and cisterna chyli rupture. There was one postoperative complication, port-site metastasis. There was no conversion to laparotomic surgery. The median follow-up period was 33 months. Thirteen of the patients have no evidence of recurrences, however one patient died after 22 months after the surgery.Laparoscopic restaging surgery, performed by a specialized laparoscopic oncologist with sufficient laparoscopic experience and a well-trained operating team, is both feasible and effective in the management of unexpected ovarian malignancies.